BEAVERTON, Ore., March 8, 2007 (PRIME NEWSWIRE) -- Wall Street Savant, LLC (www.wallstreetsavant.com) today announced initiation of Profile Coverage on Martin Nutraceuticals, Inc. (Pink Sheets:MNCL) on its website. Martin Nutraceuticals is a family of nutraceuticals developed to enhance the pleasure of life and lifestyle. In order to acquire a level of excellence, Martin Nutraceuticals has instituted an advisory board that includes Dr. Anthony W. Martin, who brings over 30 years of Naturopathic and Supplementation experience to the team at Martin Nutraceuticals. Dr. Martin has spent several years on perfecting the nutraceutical supplementation offered by Martin Nutraceuticals. With the culmination of over 20 years of research in the natural/alternative medicine market, Dr. Martin has revolutionized the ability to integrate natural systemic enzymes in each dose, which results in a faster reaction time, leading to improved symptoms within the first few days.
To view Martin Nutraceuticals, Inc.'s Profile please visit www.wallstreetsavant.com.
About WallStreetSavant.com
WallStreetSavant.com is a leading online financial portal where investors can discover an array of financial tools to help build their investment IQ. WallStreetSavant.com also provides comprehensive profiles on undiscovered and under-followed micro and small-cap companies as well as well researched opinions on stocks for active traders. The comprehensive profiles are featured on WallStreetSavant.com and members are kept abreast on all new developments through regular email updates.
To join our free email list please click here: http://www.wallstreetsavant.com/mailer/user/register.php
To feature your publicly traded company on WallStreetSavant.com, please contact us at 1-800-281-6469 or via email at info@wallstreetsavant.com.
Forward-Looking Statements: With the exception of historical information, this news release and accompanying information may include forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those anticipated as a result of various risks. There are numerous factors that could contribute to such differences; therefore, such projected events and anticipated results are not warranties or guarantees that such events will occur or that the Company will achieve such results. For more information about this corporation and risks involved in the investment of their publicly traded shares, please see the Company's web site, and/or documents filed with the SEC. Disclosure: Wall Street Savant LLC expects to be compensated thirty four thousand five hundred dollars by a third party for profile coverage. Wall Street Savant LLC is not a registered investment advisers or broker/dealer. Wall Street Savant LLC makes no recommendation that the purchase of securities of companies profiled in its web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.